1028539 results for Number of ongoing Clinical Trials (for drugs) involving Inappropriate ADH Syndrome (Syndrome Of Inappropriate Antidiuretic Hormone Hypersecretion) by Phase Clear

Advanced Search

Seraching for: SearchTermHere Clear
  • Statistics Type
Title Statistics Type Geography Measure Name Industry Published Date
Number of ongoing Clinical Trials (for drugs) involving Down Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Usher Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Sezary Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Rett Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Tourette Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Myelodysplastic Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Turner Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Alport Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Metabolic Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Antiphospholipid Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Alagille Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Fragile X Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Short Bowel Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Polycystic Ovarian Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Post Polio Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Irritable Bowel Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Guillain-Barre Syndrome by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Achromatopsia by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Oncology by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Pancreatitis by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Melanoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Osteosarcoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Oligodendroglioma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Schizophrenia by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Alopecia by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Glaucoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Glioma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Hemochromatosis by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Hypertension by Phase Other Industry Indicators Global Number of clinical trials for drugs - Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Retinoblastoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Leiomyosarcoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Pain by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Epilepsy by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Emphysema by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Immunology by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Adenocarcinoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Amyloidosis by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Meningioma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Craniopharyngioma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Neuropathy by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Amblyopia by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Achondroplasia by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Cellulite by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Leukemia by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Tuberculosis by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Fistula by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Diverticulitis by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Dermatomyositis by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Chordoma by Phase Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Number of ongoing Clinical Trials (for drugs) involving Inappropriate ADH Syndrome (Syndrome Of Inappropriate Antidiuretic Hormone Hypersecretion) by Phase
Other Industry Indicators Global Number of clinical trials for drugs Healthcare Oct 2021
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer